06/14/2021 8:07 AM
Clarín.com
Society
Updated 06/14/2021 8:07 AM
Argentina
will exceed 20 million vaccines
against the coronavirus
this Monday
, when this afternoon a new batch of 934,200 doses of the AstraZeneca vaccine arrives at the Ezeiza airport.
It is a batch of doses made with the
active ingredient produced in Argentina
, which will arrive from the United States.
Flight AM1407
is scheduled to
arrive at 5.15 pm
at Ezeiza International Airport.
This new shipment will be the fourth of this type of vaccines, which will be added to the 843,600 doses received on May 27, the 2,148,600 that arrived on May 31 and the 811,000 that arrived on the night of this Saturday, on a flight from the Aeroméxico company, directly from the Federal District.
With this item
, the exact number of doses received will be 20,677,145
: 9,415,745 correspond to Sputnik V (7,875,585 from component 1 and 1,540,160 from component 2), 4,000,000 from Sinopharm, 580,000 AstraZeneca - Covishield, 1,944 .000 AstraZeneca through the Covax mechanism and 4,737,400 will be AstraZeneca-University of Oxford doses.
A woman receives the dose of AstraZeneca's coronavirus vaccine.
Photo Maxi Failla.
Meanwhile, on Friday new contracts were announced with
Sinopharm for 2 million more doses and with Cansino for 5.4 million Convidencia vaccines
, whose authorization "on an emergency basis" was specified by the Ministry of Health, after the approval of the National Administration of Medicines, Food and Medical Technology (Anmat).
Convidencia (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) is from the Cansino Biologics Inc laboratory (Beijing Institute of Biotechnology), and it is a single dose vaccine, the third developed by China, after Sinovac and Sinopharm.
As reported over the weekend,
nearly 30% of the nation's population has already received the first dose
of the vaccine.
AFG
Look also
"Sputnik cost": why bringing the Russian Covid vaccine by plane is 20% more expensive than the Chinese one if the flight is shorter
Novavax announced that its coronavirus vaccine is more than 90% effective, even against new variants
